Genetically proxied PCSK9 inhibition is associated with reduced psoriatic arthritis risk

ConclusionsThis Mendelian randomization analysis underscores the pivotal role of PCSK9 in the etiology of psoriatic arthritis. Inhibition of PCSK9 is associated with reduced psoriatic arthritis risk, highlighting the potential therapeutic benefits of existing PCSK9 inhibitors.

Source: Inflammation Research - February 11, 2024 Category: Research Source Type: research